Discovery Life Sciences (Discovery) is a purpose-built partner supporting complex drug development and clinical research. With advanced sequencing technologies, integrated biospecimen access, and multi-omic capabilities, we support the full spectrum of genomics projects, from large-scale exploratory sequencing to targeted clinical panels and PCR-based biomarker assays.
Looking for reliable clinical comprehensive genomic profiling without a need of performance study? Explore Luminos®, Discovery’s new 164‑gene pan‑tumor CGP panel designed for fast, actionable insights. Learn more HERE.